Tag: IPO

Categories
1 Minute-Read

Gujarat Kidney IPO lists at 6% premium

Shares of Gujarat Kidney and Super Speciality Ltd made a steady debut on the stock exchanges, listing at a 6 per cent premium over the IPO price. The stock opened at around ₹120–121, compared to the issue price of ₹114, indicating healthy investor appetite.

The IPO received strong overall subscription, led by retail investors, reflecting confidence in the company’s healthcare-focused business model. Funds raised through the public issue will be used for expansion, hospital acquisitions, and purchase of medical equipment. The positive listing highlights continued interest in healthcare stocks despite mixed market conditions.

Categories
Corporate

Coal India plans IPOs for two subsidiaries

Coal India Ltd (CIL), India’s state-owned coal producer, is set to list two of its major subsidiaries , Mahanadi Coalfields Limited (MCL) and South Eastern Coalfields Limited (SECL), on stock exchanges, aiming to broaden the pipeline of public sector unit (PSU) initial public offerings (IPOs). The board has given in-principle approval, with final clearance pending regulatory and government approvals.

The move follows growing market interest in PSU IPOs, particularly after the buzz surrounding Bharat Coking Coal Ltd (BCCL), which is preparing for an IPO of around ₹1,300 crore. Analysts see Coal India’s plan as part of a broader government push to deepen capital markets, increase transparency, and unlock the intrinsic value of public enterprises.

Both MCL and SECL are among Coal India’s most productive subsidiaries. MCL, based in Odisha, is a significant contributor to national coal output, while SECL, headquartered in Chhattisgarh, operates extensive mining projects across central India. Both subsidiaries have delivered strong revenues and profits, making them attractive for public investment.

The board approval was passed via a circular resolution and will now be submitted to the Ministry of Coal and the Department of Investment and Public Asset Management (DIPAM) for final approvals. Market reaction has been positive, with Coal India shares rising in trading after the announcement.

Experts believe listing these subsidiaries could enhance shareholder returns by providing clearer valuations for the high-performing units. The move is also expected to energize the primary market for 2026, offering investors more opportunities to participate in government-linked offerings.

This development signals a strategic push by Coal India and the government to leverage market mechanisms for growth, while also giving investors a chance to own stakes in profitable PSU companies. As BCCL’s IPO proceeds, MCL and SECL listings could follow, reinforcing investor confidence in public sector offerings.

Also Read: US bans new foreign drone imports including DJI

Categories
Corporate

Meesho tops India’s 2025 IPO charts with 95% rally

Meesho has delivered one of the most remarkable stock market debuts India has seen this year, quickly emerging as the best-performing large IPO of 2025. Since listing earlier this month, the Bengaluru-based e-commerce company’s shares have surged nearly 95%, reflecting strong investor confidence in its growth story.

Priced at ₹105–₹111 per share, Meesho’s public issue raised around ₹5,400 crore and attracted robust demand across investor categories. The enthusiasm has carried over into the secondary market, with the stock witnessing sustained buying interest in the days following its listing on 10 December.

The sharp rally has translated into significant wealth creation. Meesho’s market capitalisation has climbed close to ₹98,000 crore, adding an estimated ₹47,000 crore in investor value within weeks of listing. This performance places it well ahead of other major IPOs this year, including Groww and LG Electronics India, which have posted comparatively modest gains.

Beyond the numbers, the IPO has also marked a personal milestone for the company’s leadership. Co-founder and chief executive Vidit Aatrey has entered the billionaire ranks, as the value of his stake crossed the $1-billion mark following the surge in the share price. The moment underscores how Meesho’s journey from a startup to a publicly listed company has resonated strongly with the market.

Analysts attribute the stock’s strong run to Meesho’s asset-light marketplace model, expanding user base and growing appeal among value-conscious consumers across India’s smaller cities and towns. Brokerages have highlighted improving margins and scalable operations as key factors supporting long-term growth.

At the same time, market watchers caution that the stock may see bouts of volatility in the near term. A relatively limited free float, due to lock-in restrictions on promoter and early investor holdings, could amplify price movements until more shares become available for trading in 2026.

Even so, Meesho’s post-listing performance has become a bright spot for India’s capital markets, reinforcing investor optimism around digital-first consumer businesses and setting a positive tone for the country’s IPO landscape.

Also Read: Meesho founder Vidit Aatrey joins the billionaire club

Categories
1 Minute-Read

SEBI gives a go-ahead to 7 companies for IPO Launch

Capital markets regulator SEBI has cleared the draft IPO papers of seven companies, moving them closer to listing on the stock exchanges.

The firms include Turtlemint Fintech Solutions, Yashoda Healthcare Services, Fusion CX, SFC Environmental Technologies, RSB Retail India, Orient Cables India and Lohia Corp. SEBI issued its observations on their draft prospectuses between December 8 and 12.

Receipt of these observations allows companies to file final offer documents and launch their public issues within the prescribed timeline. Details such as issue size, pricing and exact IPO launch dates will be announced separately by the companies.

Categories
1 Minute-Read

Neochem Bio shares spike 10% on market debut

Neochem Bio Solutions made a strong start on the stock market on Tuesday. Its shares opened at ₹108 each, marking a 10.2% premium over the IPO price of ₹98. The stock later rose to ₹111.20, giving early investors quick gains.

The company raised ₹44.97 crore through its IPO, issuing 45.88 lakh new shares. Funds from the IPO will be used for working capital, repaying borrowings, and general corporate purposes.

The IPO was highly subscribed, with overall demand 15.5 times the issue size. Qualified institutional buyers applied for 21.97 times, non-institutional investors for 21.15 times, and retail investors for 9.42 times of the shares offered.

Neochem Bio Solutions produces specialty performance chemicals for industries like textiles, home and personal care, water treatment, paints, construction, and more, with a portfolio of over 350 chemical formulations.

Categories
1 Minute-Read

Ravelcare shares jump 55% on debut

Ravelcare made a strong market debut on December 8, 2025, listing at ₹201 per share on the BSE SME platform, up nearly 55% from its IPO price of ₹130.

The IPO, aimed at raising ₹24.1 crore through 18.54 lakh fresh shares, saw overwhelming demand, being subscribed around 406 times. The funds will support marketing, advertising, and a new manufacturing facility in Amravati, along with general corporate purposes.

Early grey‑market trading had indicated a strong premium, and the listing confirmed investors’ enthusiasm for the company’s beauty and personal‑care business.

Categories
Corporate

Zepto becomes public company, plans IPO by June 2026

Bengaluru-based quick-commerce startup Zepto has officially converted from a private to a public limited company, taking a major step toward launching its initial public offering (IPO). Shareholders approved the move during an extraordinary meeting on November 21. Following the approval, the company’s legal name has changed from “Zepto Private Limited” to “Zepto Limited.”

The company also updated its legal documents, including its Memorandum and Articles of Association, to comply with public company regulations. These changes allow Zepto to file its draft IPO papers with market regulators, likely in the near future.

Founded in July 2021, Zepto has grown rapidly and is now valued at around USD 7 billion. It has raised about USD 1.8 billion (approximately ₹16,000 crore) from investors so far. Despite being a relatively young startup, Zepto operates over 900 “dark stores” across India and has managed gross sales worth about USD 3 billion (around ₹26,000 crore).

However, the company has faced high operating costs and has spent between ₹1,000–1,100 crore in cash. Company insiders say that while cash burn has been significant, it is now decreasing as operations become more efficient. Order volumes are reportedly increasing by 20–25% each quarter, and the company aims for over 100% growth year-on-year.

With the conversion to a public company, Zepto is now set to take the next big step in its growth journey. The startup plans to submit its draft IPO documents to regulators this month, with an aim to go public and list its shares on the stock market by June 2026.

The move signals Zepto’s intention to tap public markets to raise funds for expansion, strengthen operations, and solidify its position in the rapidly growing quick-commerce sector. Analysts see this as a significant development, as Zepto is among the first unicorns in India’s fast-paced quick-delivery segment to take steps toward becoming a listed company.

By going public, Zepto hopes to attract more investors, scale operations, and compete effectively with other players in the sector, while giving early investors and founders a path to unlock the value of their stakes.

Also Read: HUL’s record date for demerger Dec 5, shares drop 7%

Categories
Corporate

Meesho IPO fully subscribed on Day 1, GMP ₹49

Meesho, the social commerce platform, saw its initial public offering (IPO) fully subscribed on the first day of trading on 3 December 2025. The IPO drew strong interest, especially from retail investors, who accounted for the largest share of demand.

The IPO was priced between ₹105 and ₹111 per share, with each lot comprising 135 shares. By the end of Day 1, the retail portion was subscribed 3.1 times, while non-institutional investors (NIIs) applied for 1.23 times their allocation. Qualified institutional buyers (QIBs) showed limited interest, subscribing only 0.16 times.

In the grey market, Meesho shares traded at a premium of ₹49, indicating a potential listing price of around ₹160 per share. This points to a possible 44% gain for early investors if the stock opens at the grey market price.

Meesho has established itself as a low-cost, high-volume e-commerce platform targeting value-conscious customers, particularly in smaller cities and towns. The company has achieved cash-flow positivity in FY25, although it is not yet profitable overall. Analysts say Meesho’s large user base and high transaction volume give it strong growth potential, but consistent profitability will be key for long-term success.

Brokerages and market experts generally recommend subscribing for the IPO, citing Meesho’s scale and market position. At the same time, they advise caution, as the company’s ability to convert growth into profits remains uncertain.

Meesho’s IPO has generated strong investor interest, driven mainly by retail demand and buoyed by a high grey market premium. The debut highlights the popularity of e-commerce platforms in India and reflects investor confidence in companies with rapid growth and a wide market reach.

Also Read: AI leader Anthropic prepares for possible IPO in 2026

Categories
Corporate

Exato Technologies IPO sees record 700× subscription

The IPO of Exato Technologies has turned into one of the most talked-about SME issues of the year, thanks to unusually high investor interest and a sharp jump in its grey-market premium (GMP). The bidding for the IPO closed on Monday with extraordinary subscription numbers, showing strong appetite from retail and small investors.

By the final day, the IPO was subscribed over 700 times, making it one of the most oversubscribed SME offerings in recent months. Most of the buying came from retail and non-institutional investors, while institutional participation remained comparatively lower. Such a high subscription level suggests strong confidence in the company’s business and future prospects.

Along with this demand, the grey-market premium also climbed steadily. As of the closing day, unofficial market reports showed a GMP of around ₹150 above the upper IPO price, indicating a possible 100%+ listing gain. This means that if the trend holds, the stock may list at nearly double the issue price.

Exato Technologies had set its price band at ₹133–₹140 per share, with the minimum application size being 2,000 shares, making the smallest investment roughly ₹2.8 lakh. The IPO size is ₹37.45 crore, including a fresh issue as well as an offer for sale by existing shareholders.

The company has announced that the allotment of shares will likely be finalised on December 3, with refunds and demat credits expected on December 4. The shares are scheduled to list on the BSE SME platform on December 5, 2025.

Founded in 2016, Exato Technologies offers technology and customer-experience solutions to businesses across banking, healthcare, retail, telecom, BPO and other sectors. It sells a mix of digital products and services, including analytics tools, communication solutions, and automation platforms. Some of its well-known clients include MakeMyTrip, RBL Bank, and WNS.

The company plans to use a part of the IPO money to strengthen working capital, invest in product upgrades, and reduce certain borrowings.

Given the extremely high subscription and strong GMP, market watchers expect the stock to list with sizable gains. Investors who applied for the IPO will be eagerly waiting for the allotment outcome.

Also Read: Vidya Wires opens ₹300 cr IPO on December 3

Categories
Corporate

Ravelcare SME IPO ₹24 crore, shares ₹123–₹130

Ravelcare, a personal-care and beauty brand, will open its SME IPO on December 1, closing on December 3, 2025. The company aims to raise around ₹24.10 crore by issuing 18.54 lakh shares at a price band of ₹123–₹130 per share.

About ₹11.5 crore will go into advertising and marketing, while ₹7.8 crore will fund a new manufacturing facility in Amravati. The rest will support general business needs.

Founded in 2018, Ravelcare sells haircare, skincare, and body-care products online. For FY25, revenue was ₹24.98 crore with ₹5.25 crore profit. The IPO proceeds will fund growth, not payouts to existing shareholders.

Also Read: India approves ₹7,280 cr plan to make rare-earth magnets